Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene

Neuroscience

Volumn 98, Issue 2, 2000, Pages 345-352

  Laird, J M A ^a   Olivar, T ^a   Roza, C ^a   De Felipe, C ^b   Hunt, S P ^c   Cervero, F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE NEUROCIENCIAS   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Colon; Cyclophosphamide cystitis; Neurogenic inflammation; Nociception; Substance P

Indexed keywords

CYCLOPHOSPHAMIDE; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON DILATATION; CONTROLLED STUDY; CYSTITIS; GENE DISRUPTION; HYPERALGESIA; MOUSE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; VISCERAL PAIN;

ACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; CAPSAICIN; COLON; CYCLOPHOSPHAMIDE; CYSTITIS; FEMALE; HYPERALGESIA; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; MUSTARD PLANT; NOCICEPTORS; PAIN; PHYSICAL STIMULATION; PLANT EXTRACTS; PLANT OILS; RECEPTORS, NEUROKININ-1; SUBSTANCE P; URINARY BLADDER; VISCERAL AFFERENTS;

EID: 0034036363     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00148-2     Document Type: Article

References (44)

1. Alferi A., Gardner C. The NK1 antagonist GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder. Gen. Pharmac. 29:1997;245-250.
2. Amann R., Schuligoi R., Holzer P., Donnerer J. The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats. Naunyn-Schmiedeberg's Arch. Pharmac. 352:1995;201-205.
3. Baron R., Jänig W. Afferent and sympathetic neurones projecting into lumbar visceral nerves of the male rat. J. comp. Neurol. 314:1991;429-436.
4. Brown J.L., Liu H., Maggio J.E., Vigna S.R., Mantyh P.W., Basbaum A.I. Morphological characterization of substance P receptor-immunoreactive neurones in the rat spinal cord and trigeminal nucleus caudalis. J. comp. Neurol. 356:1995;327-344.
5. Butcher J.W., De Felipe C., Smith A.J.H., Hunt S.P., Paton J.F.R. Comparison of cardiorespiratory reflexes in NK1 receptor knockout, heterozygous and wild-type mice in vivo. J. auton. nerv. Syst. 69:1998;89-95.
6. Cao Y.Q., Mantyh P.W., Carlson E.J., Gillespie A.M., Epstein C.J.H., Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:1998;390-394.
7. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol. Rev. 74:1994;95-138.
8. Chapman V., Dickenson A.H. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist, on nociceptive transmission in the rat spinal cord. Neurosci. Lett. 157:1993;149-152.
9. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J.H., Laird J.M.A., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
10. Dougherty P.M., Palecek J., Palecková V., Willis W.D. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurones after intradermal capsaicin. J. Neurophysiol. 72:1994;1464-1475.
11. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.-F., Blanchard J.-C., Laduron P.M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. natn. Acad. Sci. U.S.A. 88:1991;10208-10212.
12. Giamberardino M.A., Valente R., De Bigontina P., Vecchiet L. Artificial ureteral calculosis in rats: behavioural characterization of visceral pain episodes and their relationship with referred lumbar muscle hyperalgesia. Pain. 61:1995;459-469.
13. Honoré P., Menning P.M., Rogers S.D., Nichols M.L., Basbaum A.I., Besson J.-M., Mantyh P.W. Spinal substance P receptor expression and internalization in acute, short-term and long-term inflammatory pain states. J. Neurosci. 19:1999;7670-7678.
14. Julia V., Morteau O., Buéno L. Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats. Gastroenterology. 107:1994;94-102.
15. Laird J.M.A., Olivar T., Roza C., De Felipe C., Cervero F. Visceral hyperalgesia and acute responses to chemical but not mechanical visceral stimuli are abolished in NK1 receptor knockout mice. Soc. Neurosci. Abstr. 24:1998;881.
16. Langlois A., Diop L., Rivière P.J.M., Pascaud X., Junien J.-L. Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anaesthetised rat. Eur. J. Pharmac. 271:1994;245-251.
17. Lantéri-Minet M., Bon K., De Pommery J., Michiels J.F., Menétrey D. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Expl Brain Res. 105:1995;220-232.
18. Lippe I.T., Stabentheiner A., Holzer H. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. Eur. J. Pharmac. 232:1993;113-120.
19. Ma Q.P., Woolf C.J. Tachykinin NK1 receptor antagonist RP67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats. Eur. J. Pharmac. 322:1997;165-171.
20. Ma Q.-P., Woolf C.J. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. J. Physiol., Lond. 486:1995;769-777.
21. Maggi C.A., Lecci A., Santicioli P., Del Bianco E., Giuliani S. Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J. auton. nerv. Syst. 38:1992;201-208.
22. Mansikka H., Shiotani M., Winchurch R., Raja S.N. Neurokinin-1 receptors are involved in behavioural responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. Anesthesiology. 90:1999;1643-1649.
23. Mantyh P.W., Rogers S.D., Honore P., Allen B.J., Ghilardi J.R., Li J., Daughters R.S., Lappi D.A., Wiley R.G., Simone D.A. Inhibition of hyperalgesia by ablation of lamina I spinal neurones expressing the substance P receptor. Science. 278:1997;275-279.
24. McCarson K.E. Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurones. Neuroscience. 93:1999;361-370.
25. McLean P.G., Garcia-Villar R., Fioramonti J., Buéno L. Effects of tachykinin receptor antagonists on the rat jejunal distension pain response. Eur. J. Pharmac. 345:1998;247-252.
26. Ness T.J., Gebhart G.F. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res. 450:1988;153-169.
27. Neugebauer V., Weiretter F., Schaible H.-G. Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurones during development of acute arthritis in rat's knee joint. J. Neurophysiol. 73:1995;1574-1583.
28. Neumann S., Doubell T.P., Leslie T., Woolf C.J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature. 384:1996;360-364.
29. Nichols M.L., Allen B.J., Rogers S.D., Ghilardi J.R., Honoré P., Luger N.M., Finke M.P., Li J., Lappi D.A., Simone D.A., Mantyh P.W. Transmission of chronic nociception by spinal neurones expressing the substance P receptor. Science. 286:1999;1558-1561.
30. Olivar T., Laird J.M.A. Cyclophosphamide cystitis in mice: behavioural characterisation and correlation with bladder inflammation. Eur. J. Pain. 3:1999;141-149.
31. Pan H.-L., Bonham A.C., Longhurst J.C. Role of spinal NK1 receptors in cardiovascular responses to chemical stimulation of the gallbladder. Am. J. Physiol., Heart Circ. Physiol. 268:1995;H526-H534.
32. Perry M.J., Lawson S.N. Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurones retrogradely labelled via skin, muscle or visceral nerves. Neuroscience. 85:1998;293-310.
33. Quartara L., Maggi C.A. The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides. 32:1998;1-49.
34. Rupniak N.M.J., Carlson E., Boyce S., Webb J.K., Hill R.G. Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils. Pain. 67:1996;189-195.
35. Rupniak N.M., Tattersall F.D., Williams A.R., Rycroft W., Carlson E.J., Cascieri M.A., Sadowski S., Ber E., Hale J.J., Mills S.G., MacCoss M., Seward E., Huscroft I., Owen S., Swain C.J., Hill R.G., Hargreaves R.J. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. Eur. J. Pharmac. 326:1997;201-209.
36. Saria A., Lundberg J.M. Evans Blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Meth. 8:1983;41-49.
37. Schmidt R., Schmelz M., Forster C., Ringkamp M., Torebjörk H.E., Handwerker H.O. Novel classes of responsive and unresponsive C nociceptors in human skin. J. Neurosci. 15:1995;333-341.
38. Seguin L., Le Marouille-Girardon S., Millan M.J. Antinociceptive profiles of non-peptidergic neurokinin 1 and neurokinin 2 receptor antagonists: a comparison to other classes of antinociceptive agent. Pain. 61:1995;325-343.
39. Sluka K.A., Milton M.A., Willis W.D., Westlund K.N. Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br. J. Pharmac. 120:1997;1263-1273.
40. Smith G., Harrison S., Bowers J., Wiseman J., Birch P. Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. Eur. J. Pharmac. 271:1994;481-487.
41. Traub R.J. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain. 67:1996;151-161.
42. Treede R.-D., Meyer R.A., Raja S.N., Campbell J.N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol. 38:1992;397-421.
43. Xu X.-J., Dalsgaard C.-J., Maggi C.A., Wiesenfeld-Hallin Z. NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in the rat hindpaw: demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist MEN 10207. Neurosci. Lett. 139:1992;249-252.
44. Zimmer A., Zimmer A.M., Baffi J., Usdin T., Reynolds K., Konig M., Palkovits M., Mezey E. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc. natn. Acad. Sci. U.S.A. 95:1998;2630-2635.